Gelteq Ltd GELS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.54
- Day Range
- $0.50–0.55
- 52-Week Range
- $0.39–2.02
- Bid/Ask
- $0.46 / $0.54
- Shares Outstanding
- 10.71M
- Market Cap
- $5.62M
- Volume/Avg
- 39,150 / 4M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 57.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8
- Website
- https://www.gelteq.com
Valuation
|
Metric
|
GELS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.67 |
Price/Sales | 57.13 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GELS
|
|---|---|
Quick Ratio | 0.07 |
Current Ratio | 0.09 |
Interest Coverage | −2.26 |
Quick Ratio
GELS
Profitability
|
Metric
|
GELS
|
|---|---|
Return on Assets (Normalized) | −33.82% |
Return on Equity (Normalized) | −46.23% |
Return on Invested Capital (Normalized) | −25.85% |
Return on Assets
GELS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Mw<>ks$ | LOCK|#<gF | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|pGFX!T | LOCK|K@% | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|?m^rFLq | LOCK|?$@c | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|M^VvSp^b | LOCK|$<H | $32B | |||
| Viatris Inc
VTRS
| LOCK|N><BmD | LOCK|QLM | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?G | LOCK|dQ# | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|T!ll!% | LOCK|&B$ | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|ms#QH> | LOCK|Z<b | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|y%kpG% | LOCK|K#@n | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|VxMB^# | LOCK|$@ | $1B |
United States